Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada Lifts Apotex Indian Sites Ban, FDA To Follow?

This article was originally published in PharmAsia News

Executive Summary

Canada has lifted a ban on imports from two Indian pharmaceutical plants owned by Canadian generics giant Apotex, a year after halting shipments over allegations that company employees had faked drug test results.

Advertisement

Related Content

Manufacturing Compliance In Brief: Seven US FDA Warning Letters, Two EU GMP Non-Compliance Notices

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC089153

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel